InsidersTradesSigma
Track the 파마리서치바이오 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 파마리서치바이오 has published 11 insider filings. Market capitalisation: €128.4bn. The latest transaction was reported on 4 March 2026 (Sale). Among the most active insiders: 신한캐피탈. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
11 of 11 declarations
파마리서치바이오 operates in the health and pharmaceutical sector, listed on the XKRX market. The company focuses on the research and development of biopharmaceutical solutions.